Bifikafusp alfa

Product Specifications

CAS Number

1957239-90-5

Target

Interleukin

Related Pathways

Immunology/Inflammation

Bioactivity

Bifikafusp alfa (L19-IL2) is an immunotherapeutic fusion protein combining human L19 antibodies with the cytokine interleukin 2 (IL2), targeting the extra domain B (EDB) of fibronectin, and has demonstrated anticancer activity [1].

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-41072IR 0.1 mL

Rabbit Polyclonal Swine Influenza A H1N1 Nucleocapsid Antibody [DyLight 755]

Ask

View Details

MBS6289922-01 0.1 mL

CTSK, ID (E112) (CTSK, CTSO, CTSO2, Cathepsin K, Cathepsin O, Cathepsin O2, Cathepsin X) (MaxLight 750)

Ask

View Details

MBS6289922-02 5x 0.1 mL

CTSK, ID (E112) (CTSK, CTSO, CTSO2, Cathepsin K, Cathepsin O, Cathepsin O2, Cathepsin X) (MaxLight 750)

Ask

View Details

MBS3247286-01 0.1 mg

BYSL Peptide - middle region

Ask

View Details

MBS3247286-02 5x 0.1 mg

BYSL Peptide - middle region

Ask

View Details

MBS1606082-01 48 Well

Human Cytoplasmic dynein 1 heavy chain 1, DYNC1H1 ELISA Kit

Ask

View Details